Precision for Medicine Reels in $150M in Private Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Precision for Medicine, a Chevy Chase, Md.-based startup offering a variety of services for life science companies, has brought in $150 million in private funding, the firm said this week.

The company is focused on providing bioservices, such as biobanking, biospecimen management, and biomarker identification and validation, as well as consulting and advisory services for firms developing or offering products for "patient-centered, precision medicine."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.